Elsbeth's Valentine's Episode Makes Me Want More Of Carrie Preston's Dreamy Firefighter, But Matthew Broderick As The Next Celeb Guest Makes My Broadway H…
Elsbeth continues to pack in great celebrity guests, and the costume designer has me hyped for Matthew Broderick.
Yahoo1d
Who Is Angus in Elsbeth? Ioan Gruffudd’s Character in S02E11 Explained
Tom Hanks & Rita Wilson Walk Out Of ‘SNL50’ Concert After Jimmy Fallon Said No Awards Would Be Given Out In Funny Bit ...
PBS2d
Amazing Grace
When Grace Day decided to become a lawyer, she didn't expect to endure torment from her peers and professors. But once she entered law school, she discovered most people believed women didn't ...
Benzinga.com5d
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
US new drug application submission is expected in the first half of 2025. Concurrently, Grace Therapeutics announced a private placement of approximately $30 million consisting of initial upfront ...
Yahoo Finance5d
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
PRINCETON, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE), formerly Acasti Pharma Inc. (Grace Therapeutics or the Company), a late ...
Yahoo Finance5d
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
On Monday, Grace Therapeutics, Inc. (NASDAQ:GRCE), formerly b, announced topline data from its Phase 3 STRIVE-ON safety trial of GTx-104 compared with oral nimodipine in patients hospitalized with ...
Business Insider5d
Grace Therapeutics announces private placement financing of up to $30M
Grace Therapeutics (GRCE) announced that it has entered into securities purchase agreements with new and existing healthcare focused institutional investors to raise up to approximately $30M in ...
Business Insider5d
Grace Therapeutics announces results from Phase 3 STRIVE-ON trial
Grace Therapeutics (GRCE) announced that its Phase 3 STRIVE-ON safety trial met its primary endpoint and provides evidence of clinical benefit when compared to orally administered nimodipine. The ...
Yahoo Finance5d
Grace Therapeutics Announces Private Placement Financing of up to $30 Million
PRINCETON, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE), formerly Acasti Pharma Inc. (Grace Therapeutics or the Company), a late ...
Nasdaq5d
Grace Therapeutics Phase 3 STRIVE-ON Safety Study Meets Primary Goal
(RTTNews) - Grace Therapeutics, Inc. (GRCE), a late-stage biopharma company, Monday said Phase 3 STRIVE-ON safety study met its primary goal. The STRIVE-ON study was designed to evaluate GTx-104 ...
Yahoo Finance5d
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
On Monday, Grace Therapeutics, Inc. (NASDAQ:GRCE), formerly b, announced topline data from its Phase 3 STRIVE-ON safety trial of GTx-104 compared with oral nimodipine in patients hospitalized with ...
Business Insider5d
Grace Therapeutics Announces Private Placement Financing of up to $30 Million
Craig-Hallum is acting as a financial advisor to the Company. Pursuant to the terms of the securities purchase agreements, Grace Therapeutics will issue an aggregate of 4,418,292 shares of its ...